{"doc_desc":{"title":"The European Schizophrenia Cohort","idno":"FRESH-PEF73208-en","producers":[{"name":"Jean-Michel AZORIN","affiliation":"ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE (AP-HM)"}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF73208-en","IDno":{"metadata_no":[{"agency":"PEF","code":"73208"},{"agency":"FReSH","code":"FRESH-PEF73208"}]},"title":"The European Schizophrenia Cohort","alternate_title":"EuroSC"},"study_authorization":{"agency":[]},"authoring_entity":[{"type":"investigator","name":"Jean-Michel;AZORIN","PILabo":"AP-HM Southern Regional Hospitals","affiliationName":"ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE (AP-HM)","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"IdRef","uri":"029037271","role":"pi id"},{"title":"SIREN","uri":"261300081","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"","isContact":"No"},{"type":"investigator","name":"Paul;BEBBINGTON","PILabo":"UCL","affiliationName":"UNIVERSITY COLLEGE LONDON","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"","uri":"","role":"pi id"},{"title":"SIREN","uri":"919189316","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"p.bebbington@ucl.ac.uk","isContact":"Yes"}],"oth_id":[{"name":"EuroSC Research Group (Germany, England, France)","type":"collaboration"}],"production_statement":{"prod_place":"Epidemiology France Portal (PEF)","producers":[{"name":"ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE (AP-HM)","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/002cp4060","role":"sponsor id"},{"title":"SIREN","uri":"261300081","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":"GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/04pz7b180"}]},{"name":"LUNDBECK SAS","extlink":[{"title":"SIREN","uri":"552123200"}]}]},"distribution_statement":{"contact":[{"name":"Paul;BEBBINGTON","email":"p.bebbington@ucl.ac.uk","type":"contact","affiliationName":"UNIVERSITY COLLEGE LONDON","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/02jx3x895","role":"organisation id","title":"ROR"},{"uri":"919189316","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[{"keyword":"schizophrenia"},{"keyword":"management"},{"keyword":"treatment"},{"keyword":"quality of life"},{"keyword":"care"},{"keyword":"cost"}],"topics":[{"topic":"Psychiatry","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/3de50dee-da1c-4791-a386-56bca24a5fed"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D011570"}]},{"topic":"Schizophrenia","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/1683919430","title":"CIM-11"}]},{"topic":"Healthcare system determinants: Use of care","vocab":"health determinant"},{"topic":"Healthcare system determinants","vocab":"health determinant"}],"purpose":"The main aim of EuroSC is to report on the different types of treatment and care, as well as clinical outcome. Secondary aims include: assessment of treatment requirements in relation to outcome, calculation of resource usage with regards to different care methods and identification of prognostic factors.","abstract":"","coll_dates":[{"start":"1998-01-01","end":"2002-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individuals","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Male\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"Female\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Young Adult (19 to 24 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adult (25 to 44 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Middle Aged (45 to 64 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients population\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Patients between 18 and 64 years old at baseline;  Established schizophrenia diagnosis;  Participant consent\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Clinical data','Participant-reported health data']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Health event\/morbidity\r\nHealth care consumption and services\r\nQuality of life\/health perception"}]},"method":{"data_collection":{"time_method":"","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Other\"}']","sample_frame":{"frame_unit":{"unit_type":"['Through organizations (health services or institutions, schools, businesses, etc.)']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"Transcription\",\"vocab\":\"CESSDA\"},\"value\":\"Converting or copying information into a structured record\"}"],"research_instrument":"Access on specific project only","sources":[],"target_sample_size":"[1000-10000[ individuals","response_rate":"France: 288; UK: 302; Germany: 618"},"method_notes":"Observational Study","study_class":"Unknown","notes":[{"subject":"research type","values":["Observational Study"]},{"subject":"observational study method","values":["Cohort study"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"Restricted access\",\"extLink\":[{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_16ec\"}]}"},"dataset_use":{"restrictions":"","conditions":"Contact the principal investigator","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"en","originLang":"en","autoTranslation":false,"status":"imported","creationDate":"26-08-2015","lastUpdatedAuto":null,"lastUpdatedManual":"05-09-2017","isContributorPI":"No","contributorName":"Paul BEBBINGTON","contributorAffiliation":"UNIVERSITY COLLEGE LONDON","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[]},"relatedDocument":[{"type":"","title":"","link":"http:\/\/www.biomedcentral.com\/1472-6963\/12\/269#B4"}],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":["Other","Industry"],"otherFundingAgentType":["",""]},"sponsor":{"sponsorType":["Public (France)"],"otherSponsorType":[""]},"governance":{"committee":""},"collaborations":{"networkConsortium":"Yes"},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":"Yes","followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"By medical staff in the centres concerned.","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":"No"},"geographicalCoverage":{"geoDetail":"Europe \u2014 France (Lille, Lyon, Marseilles, Clermont-Ferrand, Toulon)"},"dataTypes":{"clinicalDataDetails":"Psychiatric history, sociodemographic information, diagnosis, treatment, psychiatric and social state (SCAN SCAN, Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale for Schizophrenia (CDSS), Clinical Global Impression (CGI), Global Assessment of Functioning (GAF), Global Assessment of Relational Functioning (GARF)) medication use and side effects, treatment adherence (Rating of Medication Influences (ROMI) Scale,), healthcare system pathway and usage of service resources.","biologicalDataDetails":"","isDataInBiobank":"No","biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":"Yes","fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}